DarioHealth Reports Fourth Quarter and Full Year 2020 Results and Operational Highlights USA - English Successfully secured multiple accounts in the B2B channel which are already enrolling members and generating revenue Upright acquisition expands digital therapeutics offering to include musculoskeletal, attracting interest from existing and prospective B2B2C customers Completed financing with elite healthcare funds provides capital to execute on growth initiatives with cash and cash equivalents of approximately $90 million at closing of the financing Company to host conference call and webcast 8:30 am ET today. News provided by Share this article Share this article NEW YORK, March 9, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the fourth quarter and full year 2020 and provided a corporate and commercial update.